DE3025579A1 - Aryl-1-arylsulfonyl-4 gamma -aminopropoxy-3-1h-pyrazole, verfahren zu ihrer herstellung und sie enthaltende mittel - Google Patents

Aryl-1-arylsulfonyl-4 gamma -aminopropoxy-3-1h-pyrazole, verfahren zu ihrer herstellung und sie enthaltende mittel

Info

Publication number
DE3025579A1
DE3025579A1 DE19803025579 DE3025579A DE3025579A1 DE 3025579 A1 DE3025579 A1 DE 3025579A1 DE 19803025579 DE19803025579 DE 19803025579 DE 3025579 A DE3025579 A DE 3025579A DE 3025579 A1 DE3025579 A1 DE 3025579A1
Authority
DE
Germany
Prior art keywords
formula
radical
aryl
arylsulfonyl
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19803025579
Other languages
German (de)
English (en)
Inventor
Gilles Monnier
Marcel Pesson
Henri Techer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Roger Bellon SA
Original Assignee
Laboratoire Roger Bellon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Roger Bellon SA filed Critical Laboratoire Roger Bellon SA
Publication of DE3025579A1 publication Critical patent/DE3025579A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28Two oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE19803025579 1979-07-05 1980-07-05 Aryl-1-arylsulfonyl-4 gamma -aminopropoxy-3-1h-pyrazole, verfahren zu ihrer herstellung und sie enthaltende mittel Withdrawn DE3025579A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7917507A FR2460299A1 (fr) 1979-07-05 1979-07-05 Nouveaux derives du pyrazole et leur application therapeutique

Publications (1)

Publication Number Publication Date
DE3025579A1 true DE3025579A1 (de) 1981-01-15

Family

ID=9227565

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803025579 Withdrawn DE3025579A1 (de) 1979-07-05 1980-07-05 Aryl-1-arylsulfonyl-4 gamma -aminopropoxy-3-1h-pyrazole, verfahren zu ihrer herstellung und sie enthaltende mittel

Country Status (10)

Country Link
US (1) US4337263A (enExample)
JP (1) JPS5615271A (enExample)
BE (1) BE884189A (enExample)
CA (1) CA1152507A (enExample)
DE (1) DE3025579A1 (enExample)
ES (1) ES8102561A1 (enExample)
FR (1) FR2460299A1 (enExample)
GB (2) GB2063870B (enExample)
IT (1) IT8068062A0 (enExample)
NL (1) NL8003888A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994013643A1 (en) * 1992-12-17 1994-06-23 Pfizer Inc. Pyrazoles and pyrazolopyrimidines having crf antagonist activity
EP0691128A1 (en) * 1994-06-15 1996-01-10 Pfizer Inc. Methods of administering CRF antagonists

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA857592B (en) * 1984-10-17 1986-05-28 Heumann Ludwig & Co Gmbh Pyrazole derivatives,processes for their preparation and pharmaceutical preparations containing these compounds
US4964895A (en) * 1987-06-08 1990-10-23 Monsanto Company Substituted 4-(4-nitrophenoxy) pyrazoles and their use as herbicides
US6005109A (en) * 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
US6103900A (en) * 1992-12-17 2000-08-15 Pfizer Inc Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
EP1634872A1 (en) * 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Pyrazole derivatives as sigma receptor inhibitors
US7696199B2 (en) * 2004-08-27 2010-04-13 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
MX2007002341A (es) * 2004-08-27 2007-09-25 Esteve Labor Dr Inhibidores del receptor sigma.
WO2007098953A1 (en) * 2006-03-01 2007-09-07 Laboratorios Del Dr. Esteve, S.A. Pyrazole derivatives as sigma receptor inhibitors
EP1829875A1 (en) 2006-03-01 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Pyrazole derivatives as sigma receptor inhibitors
EP1829866A1 (en) * 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
EP1829867A1 (en) 2006-03-03 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Imidazole compounds having pharmaceutical activity towards the sigma receptor
EP2529793B1 (en) * 2007-06-08 2016-08-10 Georgia State University Research Foundation, Inc. Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2395003A1 (en) 2010-05-27 2011-12-14 Laboratorios Del. Dr. Esteve, S.A. Pyrazole compounds as sigma receptor inhibitors
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
TW201607538A (zh) 2013-12-17 2016-03-01 以斯提夫博士實驗室股份有限公司 血清素-去甲腎上腺素再攝取抑制劑(SNRIS)和σ受體配體組合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI34517A (fi) 1962-12-08 1964-10-10 Laeaeketehdas Orion Oy 5-pyratsolyylialkamiinieetterien valmistusmenetelmä
JPS4832112B1 (enExample) * 1969-10-03 1973-10-04
DE2409753A1 (de) * 1974-03-01 1975-09-11 Basf Ag Substituierte pyrazole
FR2301250A1 (fr) 1975-02-21 1976-09-17 Bellon Labor Sa Roger Nouveaux diaryl-1, 4o-aminoalcoxy-3 pyrazoles et leurs sels

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994013643A1 (en) * 1992-12-17 1994-06-23 Pfizer Inc. Pyrazoles and pyrazolopyrimidines having crf antagonist activity
EP0691128A1 (en) * 1994-06-15 1996-01-10 Pfizer Inc. Methods of administering CRF antagonists

Also Published As

Publication number Publication date
JPS5615271A (en) 1981-02-14
IT8068062A0 (it) 1980-07-04
NL8003888A (nl) 1981-01-07
GB2063870B (en) 1983-06-22
US4337263A (en) 1982-06-29
GB2054566A (en) 1981-02-18
GB2054566B (en) 1983-05-18
CA1152507A (fr) 1983-08-23
GB2063870A (en) 1981-06-10
ES492986A0 (es) 1981-02-16
BE884189A (fr) 1981-01-05
ES8102561A1 (es) 1981-02-16
FR2460299B1 (enExample) 1983-01-14
FR2460299A1 (fr) 1981-01-23

Similar Documents

Publication Publication Date Title
DE3025579A1 (de) Aryl-1-arylsulfonyl-4 gamma -aminopropoxy-3-1h-pyrazole, verfahren zu ihrer herstellung und sie enthaltende mittel
DE2705446C2 (enExample)
DE1493955A1 (de) Verfahren zur Herstellung substituierter Sulfonanilide
DE3434947A1 (de) Isoxazolcarbonsaeure-derivate, ihre herstellung und verwendung
DE2504565A1 (de) Neue derivate von 1h-imidazo(4,5-c) pyridin-7-carboxylsaeuren und -saeureestern
DE1695186A1 (de) Verfahren zur Herstellung von Imidazolderivaten
DE3443308A1 (de) 1-heteroaryl-4-aryl-pyrazolin-5-one zur verwendung als arzneimittel
EP0185909B1 (de) 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1695774A1 (de) Neue Benzophenon-Derivate
DE2637098A1 (de) Phenoxyalkylcarbonsaeurederivate und verfahren zu ihrer herstellung
EP0008645A1 (de) Alkoxyphenylpyrrolidone, Verfahren zu ihrer Herstellung und Arzneimittel auf Basis dieser Verbindungen
DE3319956A1 (de) 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
EP0072960B1 (de) 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0177907B1 (de) Neue 2-Pyridin-thiol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE3209304C2 (enExample)
DE2242454A1 (de) 1-aethyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2929760C2 (enExample)
EP0123700A1 (de) Substituierte Picolinsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
DE2348973A1 (de) Phenylpiperazinderivate, verfahren zu ihrer herstellung und ihre verwendung
DE3020421A1 (de) Imidazoazolalkensaeureamide, neue zwischenprodukte zu ihrer herstellung, ihre herstellung und ihre verwendung in arzneimitteln
DE2640884A1 (de) Neue entzuendungshemmende l-oxo-isoindolin-derivate und verfahren zu ihrer herstellung
DE2319281A1 (de) Diuretisches und antihypertensives mittel
AT235291B (de) Verfahren zur Herstellung von neuen Benz[b]cycloalkan-1-onen
DE1907545A1 (de) Derivate von Tetrazolyalkansaeuren und Verfahren zu ihrer Herstellung
DE3322079A1 (de) Tetrahydropyridazinonderivate, verfahren zu ihrer herstellung und ihre verwendung

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee